GPT Healthcare Limited

NSE: GPTHEALTH · Unclassified

₹143.93-0.01%06 Nov 2026

Ask the data

Instant answers about GPT Healthcare Limited — computed from its filings, no language model

Market cap₹1,181 cr

Current price₹143.93

High / Low₹170 / ₹115

P/E22.7

P/B4.14

Book value₹34.8

ROE18.3%

ROCE25.0%

Debt / equity0.05

Dividend yield1.74%

EPS (TTM)₹6.35

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY24	FY25	FY26
Revenue	400.2	407.1	472.6
EBITDA	87.8	83.3	84.2
Operating margin	21.9%	20.5%	17.8%
Interest	7.1	3.5	8.2
Depreciation	18.0	19.0	27.1
Profit before tax	68.0	69.3	54.8
Tax	20.3	19.4	12.6
Net profit	47.8	49.9	42.2
EPS ₹	5.96	6.08	5.15
Operating cash flow	68.8	67.4	81.2
Capex	19.4	49.9	41.8
Dividend paid	24.0	28.7	20.5
Total assets	345.5	384.2	464.8
Equity	218.5	247.8	269.4

Quarterly performance

last 12 quarters · ₹ crore

showing latest 8 of 12 periods

	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	96.6	99.4	97.8	105.7	102.2	101.4	107.1	118.9	120.2	126.4	126.2	135.6
Operating profit	21.0	23.2	18.0	23.4	21.3	20.7	17.4	22.7	20.7	23.4	24.2	26.9
Operating margin	21.7%	23.3%	18.4%	22.2%	20.8%	20.4%	16.2%	19.1%	17.2%	18.5%	19.2%	19.8%
Other income	1.2	1.6	2.2	2.8	1.9	1.6	1.6	1.3	1.4	1.6	2.0	2.9
Interest	1.7	1.6	0.9	0.7	0.8	1.0	1.6	2.2	2.3	2.2	2.2	2.1
Depreciation	4.5	4.8	4.7	4.8	4.7	4.9	6.2	6.8	7.1	7.0	6.9	7.0
Profit before tax	16.0	18.4	14.7	20.7	17.6	16.4	11.1	15.1	12.8	15.9	17.2	20.7
Tax	4.5	5.6	4.7	5.9	5.4	3.5	3.4	4.5	3.4	1.3	4.4	5.3
Net profit	11.5	12.8	10.0	14.8	12.2	12.9	7.7	10.6	9.4	14.6	12.7	15.4
EPS ₹	1.44	1.59	1.21	1.81	1.49	1.57	0.94	1.29	1.14	1.78	1.55	1.88
Revenue YoY	—	—	—	—	5.8%	2.0%	9.5%	12.5%	17.6%	24.6%	17.8%	14.1%
Profit YoY	—	—	—	—	6.8%	0.5%	-22.9%	-28.5%	-23.5%	13.0%	65.8%	45.3%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 9 periods

	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	21.2%	21.6%	20.1%	19.2%	17.1%	16.0%	15.7%	17.5%	18.3%
ROCE	31.1%	31.4%	27.9%	26.8%	24.0%	22.8%	22.1%	24.4%	25.0%
Net margin	12.3%	12.3%	12.3%	11.4%	10.1%	9.1%	8.9%	9.6%	10.2%
EBITDA margin	21.4%	21.2%	20.5%	19.9%	19.1%	18.2%	17.8%	18.5%	18.7%
Debt / equity	0.04	0.04	0.05	0.05	0.08	0.08	0.06	0.06	0.05
Interest coverage	15.30	18.67	20.99	16.52	11.63	8.82	7.66	7.95	8.64
Asset turnover	1.15	1.17	1.06	1.08	0.93	0.97	1.02	1.06	1.06

Balance sheet

equity vs borrowings over time · ₹ crore

	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	82.0	82.0	82.0	82.0	82.0	82.0
Other equity / reserves	136.4	148.9	165.8	171.8	187.4	203.1
Total equity	218.5	231.0	247.8	253.8	269.4	285.2
Borrowings	12.4	9.2	13.3	20.3	16.1	14.9
Current liabilities	77.2	63.7	74.2	84.7	79.5	82.4
Non-current liabilities	49.8	52.1	62.2	125.0	115.8	112.4
Total assets	345.5	346.8	384.2	463.5	464.8	480.1
Property, plant & equipment	201.1	198.7	202.6	261.6	265.4	342.8
Capital work-in-progress	6.4	13.4	46.3	2.3	0.7	8.1
Investments	30.4	39.0	32.0	31.7	42.9	45.5
Inventories	8.2	9.1	8.8	12.3	10.6	11.6
Receivables	24.3	28.2	24.9	32.9	20.3	31.6
Cash & equivalents	1.7	3.2	1.7	1.5	4.1	0.9

Cash flow

annual · ₹ crore · line = free cash flow

	FY24	FY25	FY26
Cash from operations	68.8	67.4	81.2
Cash from investing	-25.2	-32.6	-47.2
Cash from financing	-48.5	-34.8	-31.4
Capex	19.4	49.9	41.8
Free cash flow	49.4	17.5	39.3
Dividends paid	24.0	28.7	20.5

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹342.8 cr71%

CWIP

₹8.1 cr2%

Investments

₹45.5 cr9%

Inventories

₹11.6 cr2%

Receivables

₹31.6 cr7%

Cash & equivalents

₹0.9 cr0%

Other assets

₹39.6 cr8%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
GPT Healthcare Limited	1,181	143.93	22.7	4.14	18.3%

StoxGud checklist: Bullish setup · 7/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-1.6%

6 months+1.0%

1 year-4.3%

3Y CAGR—

5Y CAGR—

10Y CAGR—

50-day avg₹148.90

200-day avg₹142.62

RSI (14)55

FAQs

What is the share price of GPT Healthcare Limited?

GPT Healthcare Limited (GPTHEALTH) closed at ₹143.93 on NSE on 06 Nov 2026.

What is the market cap of GPT Healthcare Limited?

₹1,181 crore at the latest close.

What is the P/E ratio of GPT Healthcare Limited?

22.7, on trailing-twelve-month earnings from its filings.

How fast is GPT Healthcare Limited growing?

GPT Healthcare Limited: Latest-quarter revenue is up 14.1% year on year, profit up 45.3%.

How profitable is GPT Healthcare Limited?

On a trailing-twelve-month basis return on equity is 18.3%, return on capital employed 25.0%, operating margin 18.7%, net margin 10.2%.

How much debt does GPT Healthcare Limited have?

GPT Healthcare Limited is lightly geared: debt to equity is 0.05 with borrowings of ₹15 cr against cash of ₹1 cr (balance sheet of 2026-09-30). Operating profit covers interest 8.6 times.

Financials parsed from GPT Healthcare Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from DEC '23, annual from FY24, balance sheet from Mar '24. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.